Stay updated on Alirocumab for Plaque Regression in PAD Clinical Trial
Sign up to get notified when there's something new on the Alirocumab for Plaque Regression in PAD Clinical Trial page.

Latest updates to the Alirocumab for Plaque Regression in PAD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 added; removal of notices about government funding status and operations are administrative metadata and do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a general site status notice about government funding and updated the page revision from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check28 days agoChange DetectedUI labels related to the diff view and revision notes were updated. No substantive study data or record content changes were detected.SummaryDifference1%

- Check42 days agoChange DetectedA new page revision label v3.3.4 was added and the previous v3.3.3 revision was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.3.3 was added to the page, and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer/navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check91 days agoChange DetectedThe history shows a new revision v3.3.2 replacing the previous v3.2.0. No study details, results, or eligibility information appear to be changed in the provided screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Alirocumab for Plaque Regression in PAD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab for Plaque Regression in PAD Clinical Trial page.